Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's Disease.

Cole SR, van der Meij R, Peterson EJ, de Hemptinne C, Starr PA, Voytek B.

J Neurosci. 2017 May 3;37(18):4830-4840. doi: 10.1523/JNEUROSCI.2208-16.2017. Epub 2017 Apr 17.

Genetic risk factors in Finnish patients with Parkinson's disease.

Ylönen S, Siitonen A, Nalls MA, Ylikotila P, Autere J, Eerola-Rautio J, Gibbs R, Hiltunen M, Tienari PJ, Soininen H, Singleton AB, Majamaa K.

Parkinsonism Relat Disord. 2017 Sep 29. pii: S1353-8020(17)30353-X. doi: 10.1016/j.parkreldis.2017.09.021. [Epub ahead of print]

In-hospital Complications Following Lumbar Spine Surgery in Patients with Parkinson's Disease: Evaluation of the National Inpatient Sample Database.

Baker JF, McClelland S 3rd, Line BG, Smith JS, Hart RA, Ames CP, Shaffrey C, Bess S.

World Neurosurg. 2017 Jul 12. pii: S1878-8750(17)31105-1. doi: 10.1016/j.wneu.2017.07.006. [Epub ahead of print]

Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson's Disease.

Lin WC, Chen PC, Huang CC, Tsai NW, Chen HL, Wang HC, Chou KH, Chen MH, Chen YW, Lu CH.

Front Neurol. 2017 Jun 8;8:246. doi: 10.3389/fneur.2017.00246. eCollection 2017.

Impaired frontal lobe functions in patients with Parkinson's disease and psychosis.

Thota N, Lenka A, George L, Hegde S, Arumugham SS, Prasad S, Stezin A, Kamble N, Yadav R, Pal PK.

Asian J Psychiatr. 2017 Dec;30:192-195. doi: 10.1016/j.ajp.2017.10.013. Epub 2017 Oct 28.

Drugs for Parkinson's disease.

[No authors listed]

Med Lett Drugs Ther. 2017 Nov 20;59(1534):187-194. No abstract available.

(11) C-PE2I and (18) F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.

Mov Disord. 2017 Oct 30. doi: 10.1002/mds.27183. [Epub ahead of print]

Perspective on the Road toward Gene Therapy for Parkinson's Disease.

Blits B, Petry H.

Front Neuroanat. 2017 Jan 9;10:128. doi: 10.3389/fnana.2016.00128. Review.

Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.

Singh Dolt K, Hammachi F, Kunath T.

Brain Pathol. 2017 Jul;27(4):545-551. doi: 10.1111/bpa.12526.

An altered blood-brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson's disease.

Sonia OD, Héctor ES, Greger O, Sara AB, Daniel M, Ana V.

Neuroscience. 2017 Aug 22. pii: S0306-4522(17)30589-4. doi: 10.1016/j.neuroscience.2017.08.023. [Epub ahead of print]

Metabolic Imaging in Parkinson Disease.

Meles SK, Teune LK, de Jong BM, Dierckx RA, Leenders KL.

J Nucl Med. 2017 Jan;58(1):23-28. doi: 10.2967/jnumed.116.183152.

Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations.

Sauerbier A, Jitkritsadakul O, Titova N, Klingelhoefer L, Tsuboi Y, Carr H, Kumar H, Banerjee R, Erro R, Bhidayasiri R, Schrag A, Zis P, Lim SY, Al-Hashel JY, Kamel WA, Martinez-Martin P, Ray Chaudhur

Neuroepidemiology. 2017 Aug 12;49(1-2):1-17. doi: 10.1159/000478702. [Epub ahead of print]

Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.

Reijula E, Pietilä AM, Halkoaho A, Selander T, Martikainen K, Kälviäinen R, Keränen T.

Trials. 2017 Sep 29;18(1):444. doi: 10.1186/s13063-017-2174-2.

Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells.

Takahashi H, Ishikawa H, Tanaka A.

Hum Cell. 2017 Feb 16. doi: 10.1007/s13577-017-0160-3. [Epub ahead of print]

Predictors of onset of psychosis in patients with Parkinson's disease: Who gets it early?

Lenka A, George L, Arumugham SS, Hegde S, Reddy V, Kamble N, Yadav R, Pal PK.

Parkinsonism Relat Disord. 2017 Sep 14. pii: S1353-8020(17)30344-9. doi: 10.1016/j.parkreldis.2017.09.015. [Epub ahead of print]